Search results for "Transplantation of organs"

showing 3 items of 3 documents

Nursing Students' Knowledge About Organ Donation and Transplantation: A Spanish Multicenter Study.

2019

Este artículo se encuentra disponible en la siguiente URL: https://www.sciencedirect.com/science/article/abs/pii/S0041134519311832?via%3Dihub En este artículo de investigación también participan: Carmen Bárcena-Calvo, Catalina Perelló-Campaner, Juan Manuel Arribas-Marin, Silvia García-Mayor, Maria Nelia Soto-Ruíz, Juan Carlos Navalón, Carme Bertran-Noguer, Maria Pilar Peña-Amaro, Maria Francisca Jiménez-Herrera, Rafaela Blanco-Sánchez, Maria Dolores Calvo-Sánchez, María Carmen Prado-Laguna, Alberto González-García, Adelina Martínez-Rodríguez, Pilar Bas-Sarmiento, Francisco Faus-Gabandé, Alicia Muiños-Alvarez, Loreto Peyró-Gregori, Hernández-Martínez Helena, Aida Saez, Álvaro Sánchez, Ana Ló…

AdultMaleHealth Knowledge Attitudes PracticeTissue and Organ ProcurementeducationMEDLINEEstudiantes de enfermería.Young AdultNursingSurveys and QuestionnairesCompletion rateHealth careHumansMedicineOrgan donationNursing students.Young adultTrasplantes (Medicina)TransplantationAcademic yearbusiness.industryOrgan TransplantationTransplantationTransplantation of organs tissues etc.SpainDonation of organs tissues etc.FemaleStudents NursingSurgeryObservational studybusinessDonación de órganos.
researchProduct

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Thera…

2022

Simple Summary We present the long-term results of patients receiving allogeneic stem cell transplantation (allo-SCT) for relapsed/refractory mantle cell lymphoma (R/R MCL) in the last 25 years in Spain. We conclude that allo-SCT may be a curative option in R/R MCL with a low cumulative incidence (CI) of relapse, although non-relapse mortality (NRM) is still high, which is mainly secondary to acute graft-versus-host disease (aGVHD). Results are better for fit patients, using HLA-identical (related or unrelated) or haploidentical related donors and without previous ASCT. However, the arrival of new highly effective and low toxic immunotherapeutic or targeted therapies inevitably will relegat…

CAR-T cell therapyCancer ResearchLimfomesMantle cell lymphomaAcute graft-versus-host diseaseTransplantation of organstarget therapyacute graft-versus-host diseasemantle cell lymphomaTarget therapyTrasplantament d'òrgansgraft-versus-lymphoma effectnon-relapse mortalityOncologyNon-relapse mortalityimmune system diseaseshemic and lymphatic diseasesallogeneic stem-cell transplantationmantle cell lymphoma; allogeneic stem-cell transplantation; non-relapse mortality; acute graft-versus-host disease; graft-versus-lymphoma effect; target therapy; CAR-T cell therapyLymphomasAllogeneic stem-cell transplantationCàncerGraft-versus-lymphoma effect
researchProduct

Post-transplantation cyclophosphamide after HLA identical compared to haploidentical donor transplant in acute myeloid leukemia: a study on behalf of…

2022

Post-transplantation cyclophosphamide (PTCY) effectively prevents graft-versus-host disease (GVHD) after unmanipulated HLA-haploidentical hematopoietic stem cell transplantation (HSCT) and achieves low rates of GVHD in HLA-identical transplantation. To compare the outcomes of haploidentical versus HLA identical HSCT in patients undergoing HSCT for acute myeloid leukemia (AML) using PTCY. We conducted a retrospective study of 229 patients undergoing first HSCT for AML using PTCY with additional immunosuppression, 99 from matched sibling or unrelated donor (MSD/MUD) performed in 3 hospitals and 130 from haploidentical donors (haplo group) performed in 20 hospitals within the Spanish Group of …

TransplantationTransplantation of organsAcute myeloid leukemiaTransplantation ConditioningLeucèmia mieloideCèl·lulesCell BiologyHematologyTrasplantament d'òrgansLeukemia Myeloid AcuteMyeloid leukemiasurgical procedures operativeGVHD prophylaxisHumansMolecular MedicineImmunology and AllergyPost-transplantation cyclophosphamideUnrelated DonorsCyclophosphamideRetrospective Studies
researchProduct